Vnitr Lek 2021, 67(7):E24-E27 | DOI: 10.36290/vnl.2021.117

Pitfalls of diagnosing autoimmune pancreatitis

Denisa Frajerová
II. interní oddělení - Gastroenterologie, Krajská zdravotní, a. s., Nemocnice Teplice, o. z.

The diagnosis of the rare disease autoimmune pancreatitis (AIP) is demonstrated in the case of a patient who underwent a series of examinations that were unable to unequivocally prove the diagnosis of benignity. The disease as a form of chronic pancreatitis, and the most important and first objective of the examination is to exclude malignant disease of the pancreas and biliary tract. While imaging led to suspicion of malignancy, repeated histological examinations did not confirm it. After we were able to exclude suspected carcinoma according to the available diagnostic criteria, AIP was confirmed, and a diagnosis of type I was made, which belongs to the group of diseases characterized by high levels of immunoglobulin G4 (IgG4) in the blood serum. Successful treatment with glucocorticoids was initiated with induction of disease remission. However, AIP shows frequent relapses and this should also be borne in mind during treatment. Our case report also describes such a case.

Keywords: autoimmune pancreatitis, obstructive icterus, IgG4, choledochal stenosis, pancreatic cancer.

Published: November 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Frajerová D. Pitfalls of diagnosing autoimmune pancreatitis. Vnitr Lek. 2021;67(7):E24-27. doi: 10.36290/vnl.2021.117.
Download citation

References

  1. Blaho M, Dítě P, Kunovský L, Kianička B. Autoimmune pancreatitis - An ongoing challenge. Adv Med Sci 2020; 65(2): 403-408. Go to original source... Go to PubMed...
  2. Mačinga P, Jarošová j, Špičák J a Hucl T. Imonoglobulin G4 asociované onemocnění v gastroenterologii. Vnitř Lék 2021; 67(2): 76-83. Go to original source... Go to PubMed...
  3. Dítě P. Novotný I, Kianička B et al. Autoimunitní pankreatitida - diagnostický konsenzus. Vnitř Lék 2015; 61(2): 114-118. Go to PubMed...
  4. Kunovský L, Dítě P, Blaho M, Dvořáčková J et al. Is autoimmune pancreatitis a risk factor for pancreatic adenocarcinoma? Vnitř Lék 2021; 67(1): e9-e13. Go to original source...
  5. Masamune A, Kikuta K, Hamada S et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2020; 55(4): 462-470. Go to original source... Go to PubMed...
  6. Dítě P, Ševčíková A et al. Automunitní pankreatitida v České republice - region jižní Morava. Čes a Slov Gastroent a Hepatol 2007; 61(2): 82-85.
  7. Sarles H, Sarles J‑C et al. Chronic inflammatory sclerosis of the pancreas: an autonomous pancreatic disease? Am J Dig Dis 1961 Jul; 6: 688-698. Go to original source... Go to PubMed...
  8. Yoshida K, Toki F, Takeuchi T et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40(7): 1561-1568. Go to original source... Go to PubMed...
  9. Kamisawa T, Okazaki K, Kawa S. Diagnostic criteria for autoimmune pancreatitis in Japan. World J Gastroenterol 2008; 14(32): 4992-4994. Go to original source... Go to PubMed...
  10. Kamisawa T, Funata N, Hayashi Y et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38(10): 982-984. Go to original source... Go to PubMed...
  11. Novotný I, Dítě P, Lata J et al. Autoimmune pancreatitis - recent advances Dig Dis (Basel) 2010; 28(2): 334-338. Go to original source... Go to PubMed...
  12. Feldman M et al. Sleisenger and Fortran's Gastrointestinal and Liver Disease. Vol. 1. 10th Edition, 2016: 1001.
  13. Kupka T, Novotný I, Kunovský L et al. Idiopatický střevní zánět a 1. typ autoimunitní formy pankreatitidy: kazuistika. Vnitř Lék 2019; 65(7-8): 520-523. Go to original source... Go to PubMed...
  14. Kunovský L, Dítě P, Bojková M et al. Diagnostika a terapie chronické pankreatitidy dle UEG guidelines. Vnitř Lék 2021; 67(2): 85-91. Go to original source... Go to PubMed...
  15. Löhr J‑M, Beuers U, Vujasinovic M et al. European Guideline on IgG4-related digestive disease - UEG and SGF evidence‑based recommendations. United European Gastroenterology Journal 2020; 8(6): 637-666. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.